Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
1.
J Affect Disord ; 347: 249-261, 2024 02 15.
Article in English | MEDLINE | ID: mdl-37995926

ABSTRACT

BACKGROUND: Anhedonia is a transdiagnostic symptom of severe mental illness (SMI) and emerges during adolescence. Possible subphenotypes and neural mechanisms of anhedonia in adolescents at risk for SMI are understudied. METHODS: Adolescents at familial risk for SMI (N = 81) completed anhedonia (e.g., consummatory, anticipatory, social), demographic, and clinical measures and one year prior, a subsample (N = 46) completed fMRI scanning during a monetary reward task. Profiles were identified using k-means clustering of anhedonia type and differences in demographics, suicidal ideation, impulsivity, and emotional processes were examined. Moderation analyses were conducted to investigate whether levels of brain activation of reward regions moderated the relationships between anhedonia type and behaviors. RESULTS: Two-clusters emerged: a high anhedonia profile (high-anhedonia), characterized by high levels of all types of anhedonia, (N = 32) and a low anhedonia profile (low-anhedonia), characterized by low levels of anhedonia types (N = 49). Adolescents in the high-anhedonia profile reported more suicidal ideation and negative affect, and less positive affect and desire for emotional closeness than low-anhedonia profile. Furthermore, more suicidal ideation, less positive affect, and less desire for emotional closeness differentiated the familial high-risk, high-anhedonia profile adolescents from the familial high-risk, low-anhedonia profile adolescents. Across anhedonia profiles, moderation analyses revealed that adolescents with high dmPFC neural activation in response to reward had positive relationships between social, anticipatory, and consummatory anhedonia and suicidal ideation. LIMITATIONS: Small subsample with fMRI data. CONCLUSION: Profiles of anhedonia emerge transdiagnostically and vary on clinical features. Anhedonia severity and activation in frontostriatal reward areas have value for clinically important outcomes such as suicidal ideation.


Subject(s)
Anhedonia , Mental Disorders , Humans , Adolescent , Anhedonia/physiology , Mental Disorders/diagnostic imaging , Brain , Cluster Analysis , Genetic Predisposition to Disease
2.
Hum Reprod ; 32(9): 1880-1891, 2017 09 01.
Article in English | MEDLINE | ID: mdl-28854721

ABSTRACT

STUDY QUESTION: Does developmental exposure to the combination of hyperandrogenemia and western-style diet (WSD) worsen adult metabolic function compared to either treatment alone? SUMMARY ANSWER: Young female rhesus macaques treated for 3 years, beginning at menarche, with combined testosterone (T) and WSD have increased weight gain and insulin resistance compared to controls and animals treated with either T or WSD alone. WHAT IS KNOWN ALREADY: Hyperandrogenemia is a well-established component of polycystic ovary syndrome (PCOS) and can be observed in peripubertal girls, indicating a potential pubertal onset of the disease. Obesity is often associated with hyperandrogenemia in peripubertal girls, and overweight girls appear to be at higher risk for the development of PCOS later in life. STUDY DESIGN, SIZE, DURATION: Juvenile (2.5- year old) female rhesus macaques were divided into four groups (n = 10/group): control animals receiving cholesterol implants and a control diet with 15% of calories derived from fat (C), animals receiving T implants (mean serum levels: 1.35 ± 0.01 ng/ml) and a control diet (T), animals receiving a cholesterol implant and a WSD with 36% of calories derived from fat (WSD) and animals receiving a T implant and a WSD (T + WSD). Animals were maintained on the treatments for 36 months and were 5.5 years old at study completion. PARTICIPANTS/MATERIALS, SETTING, METHODS: Metabolic testing consisted of body measurements including weight, dual-energy X-ray absorptiometry scans, activity monitoring, and glucose tolerance testing at zero months and at least once every 12 months for the remainder of the study. Indirect calorimetry and serum hormone assays were performed following 36 months of treatment. MAIN RESULTS AND THE ROLE OF CHANCE: Body weight and fat mass gain were significantly increased in T + WSD at 24 and 36 months of treatment compared to the other three groups. Log transformed fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) were significantly increased in T + WSD animals at 3 years of treatment compared to all other groups. T-treatment caused a greater rate of decline in activity after 18 months, while food intake and metabolic rate were largely unaffected by treatments. LIMITATIONS REASONS FOR CAUTION: Variability was present in the metabolic parameters measured; however, this is similar to the heterogeneity observed in human populations. WIDER IMPLICATIONS OF THE FINDINGS: Chronic hyperandrogenemia beginning at puberty may exacerbate metabolic dysfunction in women consuming a WSD and account for the increased rates of obesity and insulin resistance observed in PCOS patients. Counseling of female patient populations with elevated androgens about the potential benefit of consuming a lower fat diet could improve long-term metabolic health outcomes. STUDY FUNDING/COMPETING INTEREST(S): Eunice Kennedy Shriver National Institute of Child Health & Human Development P50HD071836 and Oregon National Primate Center Grant P51 OD011092. The authors have no competing conflict of interests to disclose.


Subject(s)
Adiposity/physiology , Body Weight/physiology , Diet, Western , Hyperandrogenism/metabolism , Insulin Resistance/physiology , Testosterone/pharmacology , Absorptiometry, Photon , Adiposity/drug effects , Animals , Body Mass Index , Body Weight/drug effects , Female , Glucose Tolerance Test , Hyperandrogenism/blood , Macaca mulatta , Testosterone/blood
3.
Acta Psychiatr Scand ; 133(4): 324-34, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26475572

ABSTRACT

OBJECTIVE: Bipolar disorder (BP) frequently co-occurs with other psychiatric disorders. We examine whether course of anxiety disorders (ANX), attention deficit hyperactivity disorder (ADHD), disruptive behavior disorders (DBD), and substance use disorders (SUD) influence likelihood of recovery and recurrence of depression and mania in BP youth. METHOD: Weekly ratings of psychiatric disorder intensity were obtained from 413 participants of the Course and Outcome of BP Youth project, followed for an average of 7.75 years. Multiple-event Cox proportional hazards regression analyses examined worsening of comorbid disorders as predictors of mood episode recovery and recurrence. RESULTS: Increased severity in ANX and SUD predicted longer time to recovery and less time to next depressive episode, and less time to next manic episode. Multivariate models with ANX and SUD found that significant effects of ANX remained, but SUD only predicted longer time to depression recovery. Increased severity of ADHD and DBD predicted shorter time to recurrence for depressive and manic episodes. CONCLUSION: There are significant time-varying relationships between the course of comorbid disorders and episodicity of depression and mania in BP youth. Worsening of comorbid conditions may present as a precursor to mood episode recurrence or warn of mood episode protraction.


Subject(s)
Anxiety Disorders/psychology , Attention Deficit Disorder with Hyperactivity/psychology , Attention Deficit and Disruptive Behavior Disorders/psychology , Bipolar Disorder/psychology , Substance-Related Disorders/psychology , Adolescent , Child , Comorbidity , Female , Humans , Male , Problem Behavior , Psychiatric Status Rating Scales , Risk Factors
4.
Acta Psychiatr Scand ; 132(4): 270-80, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25865120

ABSTRACT

OBJECTIVE: To determine the longitudinal impact of borderline personality disorder (BPD) on the course and outcome of bipolar disorder (BP) in a pediatric BP sample. METHOD: Participants (N = 271) and parents from the Course and Outcome of Bipolar Youth (COBY) study were administered structured clinical interviews and self-reports on average every 8.7 months over a mean of 93 months starting at age 13.0 ± 3.1 years. The structured interview for DSM-IV personality disorders (SIDP-IV) was administered at the first follow-up after age 18 to assess for symptoms of BPD. BPD operationalized at the disorder, factor, and symptom level, was examined as a predictor of poor clinical course of BP using all years of follow-up data. RESULTS: The number of BPD symptoms was significantly associated with poor clinical course of BP, above and beyond BP characteristics. Affective dysregulation was most strongly associated with poor course at the factor level; the individual symptoms most strongly associated with poor course were dissociation/stress-related paranoid ideation, impulsivity, and affective instability. CONCLUSION: BPD severity adds significantly to the burden of BP illness and is significantly associated with a more chronic and severe course and outcome beyond what can be attributable to BP characteristics.


Subject(s)
Bipolar Disorder/psychology , Borderline Personality Disorder/psychology , Adolescent , Affective Symptoms/complications , Affective Symptoms/psychology , Age Factors , Bipolar Disorder/diagnosis , Bipolar Disorder/epidemiology , Borderline Personality Disorder/diagnosis , Borderline Personality Disorder/epidemiology , Child , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/psychology , Female , Humans , Impulsive Behavior , Interview, Psychological/methods , Longitudinal Studies , Male , Psychiatric Status Rating Scales , Retrospective Studies
5.
Acad Psychiatry ; 39(6): 649-53, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25825227

ABSTRACT

OBJECTIVES: Psychiatric education for non-psychiatric residents varies between training programs, and may affect resident comfort with psychiatric topics. This study's goals were to identify non-psychiatric residents' comfort with psychiatric topics and to test the effectiveness of a video intervention. METHODS: Residents in various departments were given a survey. They were asked to rank their comfort level with multiple psychiatric topics, answer questions about medical decision making capacity (MDMC), watch a 15-min video about MDMC, and answer a post-test section. RESULTS: In total, 91 Internal Medicine, General Surgery, and Obstetrics and Gynecology residents responded to the study. Of the 91 residents, 55 completed the pre- and post-test assessments. There was no significant difference in correct responses. Residents' comfort levels were assessed, and a significant improvement in comfort level with MDMC was found. CONCLUSIONS: This study highlights potential opportunities for psychiatric education, and suggests brief video interventions can increase resident physicians' comfort with a psychiatric topic.


Subject(s)
Audiovisual Aids/standards , Clinical Decision-Making , Curriculum/standards , Educational Technology/methods , Internship and Residency/methods , Psychosomatic Medicine/education , Adult , Humans
6.
Int J Primatol ; 35(1): 325-339, 2014 Feb 01.
Article in English | MEDLINE | ID: mdl-24701001

ABSTRACT

Primate behavior is influenced by both heritable factors and environmental experience during development. Previous studies of rhesus macaques (Macaca mulatta) examined the effects of genetic variation on expressed behavior and related neurobiological traits (heritability and/or genetic association) using a variety of study designs. Most of these prior studies examined genetic effects on the behavior of adults or adolescent rhesus macaques, not in young macaques early in development. To assess environmental and additive genetic variation in behavioral reactivity and response to novelty among infants, we investigated a range of behavioral traits in a large number (N = 428) of pedigreed infants born and housed in large outdoor corrals at the Oregon National Primate Research Center (ONPRC). We recorded the behavior of each subject during a series of brief tests, involving exposure of each infant to a novel environment, to a social threat without the mother present, and to a novel environment with its mother present but sedated. We found significant heritability (h2 ) for willingness to move away from the mother and explore a novel environment (h2 = 0.25 ± 0.13; P = 0.003). The infants also exhibited a range of heritable behavioral reactions to separation stress or to threat when the mother was not present (h2 = 0.23 ± 0.13-0.24 ± 0.15, P < 0.01). We observed no evidence of maternal environmental effects on these traits. Our results extend knowledge of genetic influences on temperament and reactivity in nonhuman primates by demonstrating that several measures of behavioral reactivity among infant rhesus macaques are heritable.

7.
Int J Sports Med ; 25(1): 61-7, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14750015

ABSTRACT

Obesity is a major health problem in the U.S., especially for Hispanic youth. Because maximal/peak oxygen consumption (V.O (2)peak) is one predictor of future weight gain in children, valid field-based methods for determining V.O (2)peak in Hispanic children are needed. The purpose of this study was to validate a field-based aerobic fitness test, the 20-m shuttle test (20-MST), in Hispanic boys (n = 58) and girls (n = 67), 10 - 12 years old (mean age +/- SD, 10.7 +/- 0.6 y). Measured V.O (2)peak was determined during a maximal, graded treadmill test using the Bruce protocol. The 20-MST was administered per a standard protocol. Maximal speed attained on the 20-MST and age were used to estimate V.O (2)peak. An intraclass coefficient of 0.82 was obtained on 35 students (16 boys; r = 0.85 and 19 girls; r = 0.79) who completed the 20-MST twice, 1-wk apart. Estimated (44.3 ml x kg (-1) x min (-1) ) and measured (45.1 ml x kg (-1) x min (-1)) V.O (2)peak were not significantly different (p = 0.33). The correlation between the two V.O (2)peak parameters was r = 0.62; p < 0.001, the standard error of the estimate (SEE) was 3.91 ml x kg (-1) x min (-1), and 85.5 % of the measured V.O (2)peak values fell within 5.9 ml x kg (-1) x min (-1) of estimated V.O (2)peak. The weight status of the child did not significantly change these results. The 20-MST combined with the Leger et al. equation is a valid method for predicting V.O (2)peak in Hispanic youth. The test can be used to provide valuable information for intervention design and disease prevention.


Subject(s)
Aerobiosis , Hispanic or Latino , Physical Fitness/physiology , Analysis of Variance , Child , Exercise Test , Female , Humans , Male , Oxygen Consumption/physiology
8.
Arch Gen Psychiatry ; 58(11): 1057-63, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11695953

ABSTRACT

BACKGROUND: Alterations in amygdala function have been implicated in the pathophysiological characteristics of adult anxiety and depressive disorders. Studies with healthy adults and children, as well as with adults who have amygdala lesions, have found facial expressions of emotion to be useful probes of amygdala activity. Our study examined the amygdala response to fearful and neutral facial expressions in healthy, anxious, and depressed children. We hypothesized that children with anxiety and depression may show atypical amygdala responses to emotional stimuli. METHODS: Twelve children (8-16 years of age) with generalized anxiety or panic disorder and 12 healthy comparison children underwent noninvasive functional magnetic resonance imaging while viewing photographs of fearful and neutral facial expressions. In a second comparison, 5 girls with major depressive disorder were compared with 5 anxious and 5 healthy girls from the previous sample. RESULTS: Children with anxiety disorders showed an exaggerated amygdala response to fearful faces compared with healthy children, whereas depressed children showed a blunted amygdala response to these faces. In addition, the magnitude of the amygdala's signal change between fearful and neutral faces was positively correlated with the severity of everyday anxiety symptoms. CONCLUSIONS: Our results suggest that amygdala function is affected in both anxiety and depression during childhood and adolescence. Moreover, this disruption appears to be specific to the child's own rating of everyday anxiety.


Subject(s)
Amygdala/blood supply , Amygdala/metabolism , Anxiety/psychology , Depression/psychology , Facial Expression , Fear , Visual Perception , Adolescent , Amygdala/abnormalities , Anxiety/diagnosis , Child , Depression/diagnosis , Female , Humans , Magnetic Resonance Imaging , Male , Psychiatric Status Rating Scales , Severity of Illness Index , Tomography, Emission-Computed
9.
J Am Acad Child Adolesc Psychiatry ; 40(7): 762-72, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11437014

ABSTRACT

OBJECTIVE: To compare paroxetine with placebo and imipramine with placebo for the treatment of adolescent depression. METHOD: After a 7- to 14-day screening period, 275 adolescents with major depression began 8 weeks of double-blind paroxetine (20-40 mg), imipramine (gradual upward titration to 200-300 mg), or placebo. The two primary outcome measures were endpoint response (Hamilton Rating Scale for Depression [HAM-D] score < or = 8 or > or = 50% reduction in baseline HAM-D) and change from baseline HAM-D score. Other depression-related variables were (1) HAM-D depressed mood item; (2) depression item of the Schedule for Affective Disorders and Schizophrenia for Adolescents-Lifetime version (K-SADS-L); (3) Clinical Global Impression (CGI) improvement scores of 1 or 2; (4) nine-item depression subscale of K-SADS-L; and (5) mean CGI improvement scores. RESULTS: Paroxetine demonstrated significantly greater improvement compared with placebo in HAM-D total score < or = 8, HAM-D depressed mood item, K-SADS-L depressed mood item, and CGI score of 1 or 2. The response to imipramine was not significantly different from placebo for any measure. Neither paroxetine nor imipramine differed significantly from placebo on parent- or self-rating measures. Withdrawal rates for adverse effects were 9.7% and 6.9% for paroxetine and placebo, respectively. Of 31.5% of subjects stopping imipramine therapy because of adverse effects, nearly one third did so because of adverse cardiovascular effects. CONCLUSIONS: Paroxetine is generally well tolerated and effective for major depression in adolescents.


Subject(s)
Depressive Disorder/drug therapy , Paroxetine/therapeutic use , Selective Serotonin Reuptake Inhibitors/therapeutic use , Adolescent , Analysis of Variance , Antidepressive Agents, Tricyclic/therapeutic use , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Imipramine/therapeutic use , Least-Squares Analysis , Male , Paroxetine/adverse effects , Paroxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/pharmacology
10.
Biol Psychiatry ; 49(12): 1050-4, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11430846

ABSTRACT

This review examines current instrumentation for making clinical and research diagnoses of depressive disorders in children and adolescents. Reliable assessment of depression in children requires gathering information from both the parent and child, as well as from all other available information. The methodology for obtaining information from the child must be adapted to reword and better obtain information in those domains that are inherently difficult for children, including questions about internal affect state and questions requiring judgment. Because child depression is highly comorbid with other psychiatric disorders, including anxiety, attention-deficit/hyperactivity disorder (ADHD), and conduct disorder (CD), it is imperative that these and other psychiatric disorders be simultaneously assessed. A number of structured and semistructured instruments address this task well. More work is needed to decrease the time burden and cost of reliable assessment of child depression.


Subject(s)
Depressive Disorder, Major/diagnosis , Adolescent , Attention Deficit Disorder with Hyperactivity/psychology , Child , Depressive Disorder, Major/psychology , Humans , Judgment/physiology , Parent-Child Relations , Psychology, Adolescent , Psychology, Child
11.
Biol Psychiatry ; 49(11): 930-42, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11377411

ABSTRACT

BACKGROUND: This is a report of a clinical follow-up study (10-15 years later as young adults) of adolescent major depressives and normal control subjects. Polysomnographic data were obtained during the original study period when the subjects were adolescent (time 1). With clinical follow-up (time 2) assessments in hand, our objective was to ascertain whether there were any premorbid polysomnographic signs associated with depression during adolescence. METHODS: Based upon initial (during adolescence) and follow-up clinical assessments (as adults), new subject groupings were generated: depression-free normal subjects and original normal subjects who experienced a depressive episode during the follow-up period (latent depressives). Suicidality and recurrence of depression were also examined. Multivariate analysis of covariance was used to analyze group differences in sleep measures and logistic regression for predicting three outcomes: lifetime depression, lifetime suicidality, and recurrence. RESULTS: Comparison of the depression-free normal subjects, the latent depressives, and the original major depressives revealed significant differences for sleep latency and sleep period time. Comparing all lifetime depressives (original major depressives and the latent depressives) to depression-free normal subjects revealed significantly more stages 3 and 4 combined (ST34) sleep and greater sleep period times among the depressives. An analysis involving the presence or absence of suicidality revealed no overall significant differences between the groups. Comparison of the lifetime depressives grouped by nonrecurrent and recurrent depressive course to the depression-free normal subjects revealed significant difference for sleep period time. Using logistic regression, we found that a longer sleep latency and sleep period time significantly predicted lifetime depression. Gender, ST34 sleep, and an interaction term for ST34 sleep and REM latency significantly predicted lifetime suicidality. CONCLUSIONS: There was evidence of premorbid sleep abnormalities during adolescence. A general pattern of sleep disruption around sleep onset and during the first 100 min of the sleep period and overall sleep was evident among the major and lifetime depressives, involving sleep latency (initial insomnia), sleep period time (hypersomnia), REM latency, and slow-wave sleep. This adds to the body of literature that highlights the importance of the first 100 min of the sleep period in depression.


Subject(s)
Depressive Disorder, Major/diagnosis , Polysomnography/methods , Sleep, REM/physiology , Adolescent , Adult , Child , Electroencephalography , Follow-Up Studies , Humans , Severity of Illness Index
12.
Biol Psychiatry ; 49(4): 309-16, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11239901

ABSTRACT

BACKGROUND: The amygdala plays a central role in the human response to affective or emotionally charged stimuli, particularly fear-producing stimuli. We examined the specificity of the amygdala response to facial expressions in adults and children. METHODS: Six adults and 12 children were scanned in a 1.5-T scanner during passive viewing of fearful and neutral faces using an EPI BOLD sequence. All scans were registered to a reference brain, and analyses of variance were conducted on the pooled data to examine interactions with age and gender. RESULTS: Overall, we observed predominantly left amygdala and substantia innominata activity during the presentation of nonmasked fearful faces relative to fixation, and a decrease in activation in these regions with repeated exposure to the faces. Adults showed increased left amygdala activity for fearful faces relative to neutral faces. This pattern was not observed in the children who showed greater amygdala activity with neutral faces than with fearful faces. For the children, there was an interaction of gender and condition whereby boys but not girls showed less activity with repeated exposure to the fearful faces. CONCLUSIONS: This is the first study to examine developmental differences in the amygdala response to facial expressions using functional magnetic resonance imaging.


Subject(s)
Amygdala/physiology , Facial Expression , Adult , Amygdala/anatomy & histology , Arousal/physiology , Child , Female , Globus Pallidus/anatomy & histology , Habituation, Psychophysiologic/physiology , Humans , Magnetic Resonance Imaging , Male , Sex Factors , Substantia Innominata/anatomy & histology
13.
J Am Acad Child Adolesc Psychiatry ; 39(11): 1387-95, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11068894

ABSTRACT

OBJECTIVE: To evaluate parent-child bonding and familial functioning in depressed children, children at high risk for depression, and low-risk controls. METHOD: Diagnoses of children and their relatives were obtained via structured interviews with all available informants. Depressed children (n = 54) received a diagnosis of current major depressive disorder (MDD). The high-risk children (n = 21) had no lifetime diagnoses of mood disorders, but at least one first-degree relative with a lifetime history of depression. The low-risk controls (n = 23) had no lifetime psychiatric disorders and no first-degree relative with a lifetime history of mood disorders. Parent-child bonding was evaluated with the child's report on the Parental Bonding Instrument (PBI). Familial functioning was evaluated with each parent answering the Family Assessment Device (FAD). RESULTS: Significant differences were found between the MDD and low-risk children on most parameters of the PBI and FAD. The children with MDD reported significantly elevated maternal overprotection, and their fathers scored significantly lower on the FAD scales of Behavioral Control and General Functioning, compared with the high-risk children. Mothers of high-risk children had significantly lower scores on the Roles and Affective Involvement dimensions of the FAD compared with mothers of low-risk children. Current maternal depression had a deleterious effect on the child's perception of maternal protection and paternal care, mother's report on all FAD scales, and father's report on most FAD scales, whether interacting with the child's depression or existing even if the child was not depressed. CONCLUSION: Maternal depression and its interaction with the child's depression appear to have negative consequences for parent-child bonding and family functioning.


Subject(s)
Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/psychology , Family/psychology , Object Attachment , Adolescent , Case-Control Studies , Child , Cross-Sectional Studies , Depression/diagnosis , Depression/psychology , Female , Humans , Male , Mother-Child Relations , Psychiatric Status Rating Scales , Psychopathology , Risk
14.
Biol Psychiatry ; 48(10): 981-8, 2000 Nov 15.
Article in English | MEDLINE | ID: mdl-11082472

ABSTRACT

BACKGROUND: This study examined growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in a large sample of depressed children compared with normal control children. Within-subject comparisons were also performed in control subjects to examine test-retest reliability and in depressed children comparing episode versus clinical recovery. METHODS: The sample included depressed children (n = 82) and normal control children (n = 55) group-matched for age, gender, and pubertal status; the mean ages were 11.2 +/- 1.7 and 11.2 +/- 1.8 years, respectively. We gave GHRH (0.1 mcg/Kg) at 9 AM, and serum GH levels were determined every 15 min from -30 min through +90 min of the GHRH infusion. A subgroup of normal control subjects (n = 11) repeated the protocol for test-retest reliability within a 2-month interval. A subgroup of depressed children (n = 20) were restudied off all medications following full clinical remission from depression. RESULTS: The mean GH response to GHRH was significantly lower in the depressed group (8.7 ng/mL +/- SEM 0.9) compared with normal control children [12.2 ng/mL +/- SEM 1.3; t(135) = 2.59, p =.01 effect size 0.44]. The test-retest reliability of GH response to GHRH was stable (intraclass correlation =.93 for mean post-GH). The GH response to GHRH remained low in subjects restudied during clinical remission from depression. CONCLUSIONS: Depressed children show low GH response to GHRH. The measure appears to be reliable, and the low GH response continues following clinical remission. Further studies are needed to explore the mechanism and relative specificity of this finding.


Subject(s)
Depressive Disorder/blood , Growth Hormone-Releasing Hormone/pharmacology , Human Growth Hormone/blood , Child , Depressive Disorder/psychology , Female , Follow-Up Studies , Humans , Male , Psychiatric Status Rating Scales , Reproducibility of Results , Sex Characteristics
16.
J Am Acad Child Adolesc Psychiatry ; 39(10): 1253-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11026179

ABSTRACT

OBJECTIVE: To examine the presence of symptoms of atypical depression among children and adolescents with a major depressive disorder (MDD). METHOD: One thousand forty-six youths (aged 6-19 years) meeting DSM-III-R criteria for MDD were included in the study. All subjects had presented at an outpatient clinic seeking treatment and were identified as having MDD via clinical interviews using the semistructured Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode (K-SADS-P) with the youngster themselves and a parent/guardian. A diagnosis of atypical depression was derived from the symptoms of depression assessed in the K-SADS-P and required the presence of mood reactivity and at least one the following symptoms: hypersomnia, increased appetite, weight gain, or psychomotor retardation (substituted for leaden paralysis). RESULTS: One hundred sixty-two (15.5%) of the depressed youths met criteria for atypical depression. The symptoms of atypical depression were found to correlate marginally, and the diagnosis of atypical depression had marginal construct validity for both children and adolescents. CONCLUSIONS: The findings from this large sample of depressed children and adolescents suggest that atypical features of depression occur in this age group. However, the diagnosis of atypical depression appears to have only marginal construct validity for both children and adolescents.


Subject(s)
Ambulatory Care , Depressive Disorder, Major/diagnosis , Adolescent , Child , Depressive Disorder, Major/classification , Depressive Disorder, Major/psychology , Diagnosis, Differential , Female , Humans , Male , Psychiatric Status Rating Scales
17.
Arch Gen Psychiatry ; 57(9): 867-72, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10986550

ABSTRACT

BACKGROUND: Decreased growth hormone (GH) response to pharmacologic stimulation has been found in children and adolescents during an episode of major depressive disorder and after recovery. In this study, we sought to determine whether GH secretion is similarly altered in children and adolescents who had never experienced depression but were at high risk of developing depression. METHODS: Subjects were 8 through 16 years of age and selected for high- and low-risk status according to familial loading for mood disorders. Sixty-four high-risk and 55 low-risk healthy subjects participated in the study, which assessed the following GH measures: (1) GH before growth hormone-releasing hormone (GHRH) infusion, every 15 minutes for 30 minutes; (2) GH response after intravenous infusion of GHRH (0.1 microg/kg), every 15 minutes for 90 minutes; and (3) nocturnal GH every 20 minutes from 9 PM until morning awakening. RESULTS: After stimulation with GHRH, the high-risk subjects secreted significantly less GH compared with the low-risk healthy controls (effect sizes for mean and peak GH, 0.52 [P =.007] and 0.40 [P =.04], respectively). In contrast, there were no between-group differences in the pre-GHRH and nocturnal GH secretion levels. Exposure to recent stressors was not associated with GH secretion. CONCLUSIONS: Taken together with previous evidence of decreased GH after GHRH infusion in acutely depressed and recovered children, these results indicate that the decreased GH response found in high-risk subjects may represent a trait marker for depression in children and adolescents.


Subject(s)
Depressive Disorder/diagnosis , Growth Hormone-Releasing Hormone , Human Growth Hormone/blood , Adolescent , Biomarkers , Child , Depressive Disorder/blood , Depressive Disorder/epidemiology , Family , Female , Growth Hormone-Releasing Hormone/administration & dosage , Growth Hormone-Releasing Hormone/pharmacology , Human Growth Hormone/metabolism , Humans , Infusions, Intravenous , Life Change Events , Male , Mental Disorders/diagnosis , Mental Disorders/epidemiology , Psychiatric Status Rating Scales/statistics & numerical data , Risk Factors , Sleep/physiology
18.
Biol Psychiatry ; 48(1): 51-7, 2000 Jul 01.
Article in English | MEDLINE | ID: mdl-10913507

ABSTRACT

BACKGROUND: The neurodevelopment of childhood anxiety disorders is not well understood. Basic research has implicated the amygdala and circuits related to these nuclei as being central to several aspects of fear and fear-related behaviors in animals. METHODS: Magnetic resonance imaging was used to measure amygdala volumes and comparison brain regions in 12 child and adolescent subjects with generalized anxiety disorder and 24 comparison subjects. Groups were matched on age, sex, height, and handedness and were also similar on measures of weight, socioeconomic status, and full scale IQ. RESULTS: Right and total amygdala volumes were significantly larger in generalized anxiety disorder subjects. Intracranial, cerebral, cerebral gray and white matter, temporal lobe, hippocampal, and basal ganglia volumes and measures of the midsagittal area of the corpus callosum did not differ between groups. CONCLUSIONS: Although these data are preliminary and from a small sample, the results are consistent with a line of thinking that alterations in the structure and function of the amygdala may be associated with pediatric generalized anxiety disorder.


Subject(s)
Amygdala/pathology , Anxiety Disorders/pathology , Anxiety Disorders/psychology , Dominance, Cerebral , Fear , Adolescent , Amygdala/physiopathology , Brain/pathology , Case-Control Studies , Child , Female , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Pilot Projects , Psychiatric Status Rating Scales
19.
Biol Psychiatry ; 47(7): 594-604, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10745051

ABSTRACT

BACKGROUND: Early sleep is associated with an increased secretion of human growth hormone (GH) through muscarinic inhibition of somatostatin, a GH suppressant. A clinical follow-up was performed approximately 1 decade after depressed and psychiatrically "normal" control adolescents, who were now young adults, had undergone baseline serial GH measurements over a 24-hour period on the third night of sleep polysomnography studies. METHODS: The study population consisted of 77 young adults who had received a diagnosis of adolescent major depressive disorder and had participated in the adolescent sleep and neuroendocrine studies. Alternatively, the young adult subjects were assessed as normal adolescent control subjects free of any psychiatric diagnosis. Blood samples had been collected for GH every 20 min during the 24-hour period coinciding with the third consecutive night of sleep electroencephalography. Subjects, now in young adulthood, were relocated and blindly reinterviewed using the Schedule for Affective Disorders and Schizophrenia (lifetime version). The original adolescent nocturnal GH data were analyzed in light of the information obtained regarding clinical course into adulthood. RESULTS: A substantial proportion of the nominally normal control group developed at least one episode of major depression or dysthymia during the follow-up period. "Latent" depressive subjects differed from depression-free control subjects by having exhibited a significantly more rapid increase of adolescent nocturnal GH secretion following sleep onset. Of the subjects who had experienced at least one lifetime major depressive episode during the follow-up, the subgroup who would go on to make suicide attempts secreted significantly greater amounts of GH during the first 4 hours of sleep. Adults with lifetime depression exhibited significantly reduced levels of GH in the 100 min preceding sleep onset during adolescence. CONCLUSIONS: Assignment of subjects based on longitudinal clinical follow-up into adulthood revealed that the sleep-related GH secretion paradigm has predictive value for future depressive episodes and future suicide attempts. Dysfunction of complex sleep-onset mechanisms may be a premorbid marker of depression and suicidal behavior.


Subject(s)
Circadian Rhythm , Depressive Disorder/blood , Human Growth Hormone/blood , Sleep/physiology , Adolescent , Adult , Age Factors , Biomarkers/blood , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Recurrence , Suicide, Attempted
20.
J Am Acad Child Adolesc Psychiatry ; 39(3): 337-45, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10714054

ABSTRACT

OBJECTIVES: To examine the demographics and phenomenology of psychosis in a sample of children and adolescents referred to a mood and anxiety disorders clinic. METHOD: Patients (N = 2,031) were assessed with the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present Episode version and classified as definite, probable, or nonpsychotic. Clinical and demographic characteristics of the groups were compared,and symptoms of psychosis were analyzed using factor analysis. RESULTS: Definite psychotic symptoms were seen in approximately 90 (4.5%) patients: 80% of these reported hallucinations (mainly auditory), 22% delusions, and 3.3% thought disorder. Of the patients with definite psychotic symptoms, 24% had bipolar disorder, 41% had major depression, 21% had subsyndromal depression, and 14% had schizophrenia spectrum disorders (schizophrenia and schizoaffective disorders). Factor analysis of the definite psychotic symptoms yielded 4 factors: hallucinations, thought disorder, delusions, and manic thought disorder. Psychotic patients had a higher frequency of comorbid disorders and suicidal ideation than nonpsychotic patients. CONCLUSIONS: Outpatient youngsters with mood disorders frequently present with psychotic symptoms, in particular auditory hallucinations. These patients commonly have comorbid psychiatric disorders and suicidal ideation.


Subject(s)
Anxiety Disorders/diagnosis , Depressive Disorder/diagnosis , Psychotic Disorders/diagnosis , Adolescent , Adult , Anxiety Disorders/psychology , Child , Child, Preschool , Comorbidity , Delusions/diagnosis , Delusions/psychology , Depressive Disorder/psychology , Female , Hallucinations/diagnosis , Hallucinations/psychology , Humans , Male , Psychotic Disorders/psychology , Schizophrenia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...